Response Genetics Inc has announced that it is expanding the sales force for its ResponseDX genetic test panels proprietary PCR-based tests used to analyze the expression of genes that correlate with response to commonly used chemotherapy agents.
Read More
WuXi AppTec announces that it has entered into a partnership with QIAGEN to provide an integrated single solution for molecular biomarker development, validation and personalized healthcare targets to their respective client bases.
Read MoreQuidel Corp announces the signing of a definitive agreement to acquire privately held Diagnostic Hybrids, Inc. for approximately $130 million in cash.
Read MoreInverness Medical Innovations Inc announces that it has commenced a cash tender offer to acquire a majority equity interest in Standard Diagnostics (“SD”), a rapid diagnostics company in Korea.
Read More